New research looks to reduce animal testing for drug development

October 10, 2012

Researchers from Royal Holloway, University of London are looking at ways of testing the side effects of new drugs without using animals.

Currently, rodents, ferrets, dogs, house musk shrews and non-human primates are used to test for emesis (the side effect of nausea and/or vomiting) research. Emesis is reported as a possible side effect in approximately one third of medicines, including those involved in chemotherapy. If animals experience similar sensations, then testing drugs on them for emetic effects is likely to be unpleasant for them as well.

Professor Robin Williams from the School of Biological Sciences at Royal Holloway is leading a team of researchers looking at whether it is possible to use an amoeba to screen potential drugs for the likelihood to cause emesis. The researchers tested the amoeba with a range of substances that produce varying degrees of emesis and observed the organism's behavioural response. Initial results have indicated that the amoeba shows a strong response to a number of bitter tasting compounds that can cause taste aversion and emesis in humans and/or laboratory animals.

Professor Williams said: "If this all proves successful then using a social amoeba to test new could result in a large reduction in the number of animals currently used in emetic liability tests.

"This would be good news for the animals but also for pharmaceutical companies in terms of reduced costs and faster initiation of clinical studies. A better understanding of the of could also benefit other areas of human medical treatment such as the ."

Explore further: ASCO: For chemo's nausea, olanzapine beats metoclopramide

Related Stories

ASCO: For chemo's nausea, olanzapine beats metoclopramide

May 17, 2012
(HealthDay) -- For patients receiving highly emetogenic chemotherapy who experience breakthrough chemotherapy-induced nausea and vomiting, treatment with olanzapine (Zyprexa) is significantly better than treatment with metoclopramide, ...

'Disgusted' rats teaching scientists about nausea, work may lead to new cancer treatments

October 5, 2012
Nausea is a common and distressing side effect of many drugs and treatments. Unlike vomiting, nausea is not well understood, but new research by University of Guelph scientists may soon change that.

New research could significantly reduce the need for clinical animal testing

March 8, 2012
University of Southampton researchers are investigating innovative methods of testing drugs that will reduce the need for involving animals.

Recommended for you

Researchers describe mechanism that underlies age-associated bone loss

September 22, 2017
A major health problem in older people is age-associated osteoporosis—the thinning of bone and the loss of bone density that increases the risk of fractures. Often this is accompanied by an increase in fat cells in the ...

Researchers develop treatment to reduce rate of cleft palate relapse complication

September 22, 2017
Young people with cleft palate may one day face fewer painful surgeries and spend less time undergoing uncomfortable orthodontic treatments thanks to a new therapy developed by researchers from the UCLA School of Dentistry. ...

Exosomes are the missing link to insulin resistance in diabetes

September 21, 2017
Chronic tissue inflammation resulting from obesity is an underlying cause of insulin resistance and type 2 diabetes. But the mechanism by which this occurs has remained cloaked, until now.

Thousands of new microbial communities identified in human body

September 20, 2017
A new study of the human microbiome—the trillions of microbial organisms that live on and within our bodies—has analyzed thousands of new measurements of microbial communities from the gut, skin, mouth, and vaginal microbiome, ...

Study finds immune system is critical to regeneration

September 20, 2017
The answer to regenerative medicine's most compelling question—why some organisms can regenerate major body parts such as hearts and limbs while others, such as humans, cannot—may lie with the body's innate immune system, ...

Immune cells produce wound healing factor, could lead to new IBD treatment

September 20, 2017
Specific immune cells have the ability to produce a healing factor that can promote wound repair in the intestine, a finding that could lead to new, potential therapeutic treatments for inflammatory bowel disease (IBD), according ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.